top of page

Self-organising stem cells

Human blastoids.jpg

We search how genetic programmes and self-organisation mechanisms
have evolved to give rise to the specific traits of human early pregnancy.

​​​​​​​​​​​​​​

Human reproduction presents a striking evolutionary paradox. Despite our species’ extraordinary propagation, human fecundity is low and pregnancies are susceptible to prominent complications. Only about one-third of conceptions result in a live birth, mainly due to the loss of ~40% of embryos during the first weeks of pregnancy, compared with ~10% in chimpanzees, our closest relatives. Understanding this paradox requires tracing the evolutionary and developmental history of early development, especially placentation and implantation, the moment when embryonic and maternal tissues establish a crucial but conflictual integration— possibly a checkpoint— between genetically different tissues.

 

How did our embryos and uteri co-evolved? How are embryos lost? Is this due to suboptimal evolutionary tinkering (genetic drift), a trade-off, or an adaptive strategy?​ These questions have been historically unaddressable due to the inaccessibility of human early pregnancy, but models of the embryo and endometrium generated from stem cells now enable mechanistic investigations in vitro.

​​

Before it implants in the uterus (day 3-5 in mice, day 6-9 in humans), the mammalian embryo is called a blastocyst. We discovered how to promote the self-organisation of stem cells into structures that closely resemble mouse and human blastocysts, which we termed blastoids (Nature 2018, Protocol.io 2018Nature 2021, Nature protocol 2023). Blastoids are morphologically and transcriptionally close to the blastocyst (independent benchmarking of human blastoids in Nature Methods 2025), and contain analogues of all three cell types that normally develop into the complete organism (placenta, yolk sac and fetus). Blastoids can be introduced into the uterus (mouse blastoid) or combined with endometrial organoids in vitro (human blastoid) to recapitulate aspects of implantation and development. In contrast to blastocysts, blastoids can be formed in large numbers, and are suitable for screenings and genetic manipulations that underpin scientific and biomedical discoveries. As such, they provide previously inaccessible opportunities to investigate the principles of early pregnancy.

 

Using mouse and human blastoids, we investigate the principles of embryonic self-organisation, including the coordination and pacing of molecular and mechanical signaling during blastocyst development, as well as the human traits that contribute to our low fecundity, particularly the evolution of gene regulatory networks controlling cellular programs involved in blastocyst implantation. This fundamental research aims to uncover the evolutionarily inherited traits of human pregnancy and their consequences for our species.

​

Biomedical research. This research also enables us to disentangle the ineluctable constraints of pregnancy from its manageable vulnerabilities, knowledge that is essential for developing novel therapeutic approaches to global health challenges such as family planning, fertility decline, and prenatal preventive medicine. To do so, we founded dawn-bio, a biotech company that leverages blastoids for human reproductive medicine.

 

Ethical framework of stem cell-based embyo models. These advances have ethical implications and we contributed to outlining a roadmap for the gradual and justifiable use of Stem Cell-Based Embryo Models, and for the dissemination of a sensible, accurate picture of contemporary human embryology that aims to maximize public support and societal benefit (see our page on the ethics). This resulted in the inclusion of an ethical framework for Stem Cell-Based Embryo Models in the guidelines of the International Society for Stem Cell Research (2021, revised in 2024), their progressive implementation by European national ethics committees (consultant for the UK, France, the Netherlands, Scandinavia, and Germany; 2021–2024), awareness by the European Union (consultation for the Hybrida project and the ERC Executive Agency), and the creation of a working group in the EMBL Ethics Board (2024–present).

    NEWS THREAD    â€‹

​​

  20th of November 2023    We published an article about 'Changing the public perception of human embryology' that calls for sensible public communication about stem cell-based embryo models that is necessary to secure public support and to ultimately achieve societal impact.

 

  17th of August 2023    We published two papers about building an ethical framework for human embryo model research (see here and here). These manuscripts follow up on the previous ones (see here, here, here, and here) and aim to draft a roadmap for a gradual and justified usage of embryo models that maximize benefits to society. Here, we propose a refined legal definition of an embryo, suggest "tipping points" for when embryo models could eventually be afforded similar protection to that of embryos, and then revisit basic ethical principles to guide the research. 

​

  25th of January 2023    We published two detailed protocols for generating human blastoids that you can find here and here. To make the embryo model accessible, we employed three different commercially available 96- and 24-well microwell plates with results similar to our custom-made ones, and showed that blastoids also form in clinical in vitro fertilization medium and can be cryopreserved for shipping. We also explained in detail our current understanding of (1) the initial parameters sufficient to form blastocyst stage-like cells (e.g., initial cell state, initial aggregate properties, the mix of molecules necessary and sufficient to stimulate the process) and of (2) the methods to evaluate the results (e.g., obtaining efficient morphogenesis and lineages specification, matching the pace and sequence of blastocyst development, etc…). You can also read here the Twitter thread and here a blog post from Heidar Heidari Khoei.

​

  7th of July 2022     We published our paper on mouse blastoids formed with Trophectoderm Stem Cells (TESCs). Using knowledge of blastoids & blastocysts, we defined an optimal set of molecules secreted by the epiblast (inducers) that captures in vitro stable, highly self-renewing mouse trophectoderm stem cells (TESCs) better resembling the blastocyst stage as compared to Trophoblast Stem Cells (TSCs). TESCs have enhanced capacity to form blastoids that implant more efficiently in utero due to inducers not only maintaining local trophoblast proliferation and self-renewal, but also secreting WNT6/7B that stimulate uterine decidualization. As such, blastocysts & blastoids actively instruct the uterus to create a supporting surrounding. Many of these molecules are also produced by human blastocysts.

​

  26th of December 2021     The labs of Fredrik Lanner (Karolinska Institutet) and Sophie Petropoulos (Université de Montréal) led an independent consortium to benchmark the different 2021 attempts to form models of early human embryos. They included our model which, along with the one of the laboratories of Ge Guo / Austin Smith, formed cells that match well with the human blastocyst. Establishing reference maps including cells originating from pre-blastocyst and post-blastocyst conceptus is crucial to properly evaluate the generated cell types and stages. An appropriate state of the cells constituting the model (e.g., cell types, cell stage) is critical for blastoids to predict in vivo development. We commented on this Biorxiv paper as this preprint repository is wonderful not only for posting papers but also for discussing them. We hope our suggestions are helpful. See also the summarising Tweet thread by Alok Javali et al.

​

    2nd of December 2021     We published our paper on human blastoids (Open access). They form with remarkable efficiency (>70%), recapitulate the temporal sequences of blastocyst development, and form cells transcriptionally similar to the blastocyst (>97% of the cells). Beyond these essential features, we observed that blastoids attach only to hormonally-primed endometrial cells, and do so via the polar trophectoderm as in utero, which increases the confidence in the functionality of the model. This model opens an avenue for mechanistic investigations of early human development. Kim Baumann (Nature Reviews Molecular Biology) wrote a Research Highlight about it entitled A role model of human blastocysts, and Alok Javali from our lab wrote on The Node a story of this scientific journey entitled The making of... human blastoids. See also the summarising Tweet thread, by Alok Javali et al.

​

    8th of June 2021      The International Society for Stem Cell Research updated its ethical guidelines and included a framework for the use of human embryo models. This is the result of 2 years of in-depth and collegial discussions with scientists and ethicists worldwide. We also wrote a summary of the updates that was published in Stem Cell Reports.

​

   1th of May 2021      The journal of the International Society for Stem Cell Research called Stem Cell Reports allowed Jianping Fu (University of Michigan) and I (Nicolas Rivron) to prepare a special edition on embryo models. This was an opportunity to gather experts in the field, summarise the state of the art, pinpoint the potential technical and ethical pitfalls, and think of the future. It will take a village to form embryo models! You can read an editorial that we wrote and download a Snapshot to decorate your lab fridge.

​

         3rd of June 2020         The National Academies of Sciences, Engineering, and Medicine of the U.S.A. published the proceedings of a workshop held in January 2020 in Washington and termed Examining the State of the Science of Mammalian Embryo Model Systems. The scientific and biomedical perspectives opened by stem cell-based embryo models are discussed, including for blastoids.

​

        3rd of March 2020       The lab of Janet Rossant (University of Toronto) and collaborators make a detailed analysis of the single-cell RNA sequencing data from mouse blastoids. They confirm the presence of analogs of the 3 founding cell types (Epi, Tr, PrE), and their transcriptional proximity to the cells of blastocysts. They also (and mainly) question the potential for extended/expanded potential stem cells (EPSCs) to form functional trophoblasts and propose that blastocyst-like structures formed with EPSCs-only form mesoderm-like cells rather than trophectoderm-like cells.

​

  16th of December 2019     The lab of Magdalena Zernicka-Goetz (Caltech) makes use of our blastoid protocol. They confirm the presence of analogs of the 3 founding cell types (Epi, Tr, PrE), the potential to implant in utero, and then replace the embryonic stem cells with extended potential stem cells (EPSCs) to investigate their capacity to form primitive endoderm. Great follow-up!

​

       2nd of May 2018       We published our paper on mouse blastocyst-like structures formed solely from stem cells and called them blastoids. It is exciting for us to see a model of the full conceptus, which comprises analogs of the three founding lineages (epiblast, trophectoderm, primitive endoderm)! Because blastoids model a pre-implantation stage and form an analog of the trophectoderm that normally mediates the interaction with the uterus, we transferred them in utero, where they recapitulated aspects of implantation (decidualization, vascularization). However, no fetus or live mouse could form.

Affiliation

Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria

​

​

​

​

​

​

​

 

 

 

Disclaimer

Content and statements offered on this website are not representative of statements, opinions, or policy of the IMBA institute, or the Austrian Academy of Science or the Vienna Biocenter. This website is not an official media outlet of the these institutions.

IMBA.png
OAW.png
VBC.png
  • Twitter
  • YouTube

©2017 by Nicolas Rivron Lab.

bottom of page